Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic

Authors:

Abstract
The overdose crisis in the US continues to escalate, likely associated with the widespread availability of highly potent synthetic opioids, such as illicitly manufactured fentanyl and fentanyl analogs (IMFs) in the illicit drug supply.1,2 Provisional data from the Centers for Disease Control and Prevention (CDC) estimate more than 107 000 overdose deaths in the US in the 12 months ending July 2022, with more than 81 000 deaths involving opioids.3 Expanding access to medications for opioid use disorder (OUD) is a central component of the US response to the overdose crisis.4

This publication has 26 references indexed in Scilit: